ADIPOQ and fatty liver disease: However, increased visceral adipose tissue reduces the biological activity of leptin and the abundance of circulating adiponectin [13]; the former is pro-inflammatory and positively associated with total body fat [14], whereas the latter is anti-inflammatory and negatively associated with hepatic steatosis and obesity [15].